C. Astrua

发表

Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.

P. Ascierto, V. de Giorgi, S. Manoukian, 2016, Journal of the American Academy of Dermatology.

Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas

P. Quaglino, P. Savoia, C. Astrua, 2015, Dermatology.

A study of melanoma in Eastern European migrants in Italy

P. Savoia, C. Astrua, P. Fava, 2017, European Journal of Dermatology.

A traveller's wart: tungiasis.

R. Senetta, P. Quaglino, C. Astrua, 2020, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response.

P. Quaglino, S. Ribero, S. Osella-Abate, 2019, Future oncology.

Treatment of metastatic melanoma: a multidisciplinary approach.

M. Aglietta, U. Ricardi, P. Quaglino, 2017, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

Arrhythmias in a patient with metastatic melanoma treated with targeted therapy and implantable cardioverter defibrillator

P. Quaglino, S. Ribero, C. Astrua, 2017, The British journal of dermatology.

Isolation of extracellular vesicles improves the detection of mutant DNA from plasma of metastatic melanoma patients

P. Quaglino, D. Russo, N. Zarovni, 2020, Scientific Reports.

Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.

J. Scarisbrick, A. Pileri, N. Pimpinelli, 2020, The Journal of investigative dermatology.

Radiotherapy and immune checkpoints inhibitors for advanced melanoma.

U. Ricardi, P. Quaglino, C. Astrua, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management

P. Savoia, C. Astrua, P. Fava, 2016, Human vaccines & immunotherapeutics.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

J. Scarisbrick, A. Pileri, M. Maule, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

miR‐155 expression in Primary Cutaneous T‐Cell Lymphomas (CTCL)

P. Quaglino, P. Savoia, C. Astrua, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease

S. Pileri, A. Pileri, C. Agostinelli, 2017, Virchows Archiv.

Favourable prognostic role of regression of primary melanoma in AJCC stage I–II patients

R. Senetta, P. Quaglino, P. Savoia, 2013, The British journal of dermatology.

Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

S. Mocellin, A. Testori, V. Chiarion-Sileni, 2015, European journal of cancer.

Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients.

G. Argenziano, K. Peris, M. Pizzichetta, 2015, Dermatology.

Cutaneous adverse reactions following SARS‐CoV‐2 vaccine booster dose: a real‐life multicentre experience

I. Zalaudek, A. Di Stefani, R. Senetta, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

CD38 Expression by Circulating and Skin-Infiltrating Lymphocytes from Sezary Syndrome Patients: A Flow Cytometry and Immunohistochemistry Study

R. Senetta, P. Quaglino, S. Ribero, 2022, Disease markers.

Reply to ‘The first dose of COVID‐19 vaccine may trigger pemphigus and bullous pemphigoid flares: is the second dose therefore contraindicated?’ by Damiani G et al.

R. Senetta, P. Quaglino, S. Ribero, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

From the Aosta Valley to Sicily: differences in clinico-pathologic features and distribution of risk factors in Italian melanoma patients: a multi center survey from the GIPME

E. Giuliani, K. Peris, M. Pizzichetta, 2013 .

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

J. Scarisbrick, A. Pileri, R. Willemze, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Bexarotene as maintenance treatment after therapies other than skin‐directed therapy in advanced‐stage mycosis fungoides: a pilot study

A. Pileri, N. Pimpinelli, F. Fuligni, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: an unusual clinical presentation

P. Savoia, C. Astrua, P. Fava, 2015, European Journal of Dermatology.

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium.

J. Scarisbrick, A. Pileri, R. Willemze, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Electrochemotherapy for the treatment of melanoma skin metastases in the era of new drugs

S. Ribero, F. Picciotto, C. Astrua, 2017 .